Biomerica Inc (BMRA) stock
BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3049% below fair value
$1.24−0.08 (-6.44%)
Close on Nov 17, 2026Market cap $5.68MP/E –Yield –
Biomerica total assets
Total assets on the balance sheet at the end of each period.
Biomerica's total assets was $8.07M at Aug 31, 2026. For fiscal 2026 it was $6.76M, up 13.7% from the year before. Over ten years it grew 1.7% a year on average. The highest annual figure on record is $17.26M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | $6.76M | +13.7% |
| FY2025 | May 31, 2025 | $5.95M | -35.8% |
| FY2024 | May 31, 2024 | $9.25M | -36.0% |
| FY2023 | May 31, 2023 | $14.45M | +27.1% |
| FY2022 | May 31, 2022 | $11.37M | -3.8% |
| FY2021 | May 31, 2021 | $11.82M | -31.5% |
| FY2020 | May 31, 2020 | $17.26M | +229.1% |
| FY2019 | May 31, 2019 | $5.25M | +0.4% |
| FY2018 | May 31, 2018 | $5.22M | +4.1% |
| FY2017 | May 31, 2017 | $5.02M | -12.4% |
| FY2016 | May 31, 2016 | $5.73M | -6.5% |
| FY2015 | May 31, 2015 | $6.12M | -5.3% |
| FY2014 | May 31, 2014 | $6.47M | +1.2% |
| FY2013 | May 31, 2013 | $6.39M | +14.8% |
| FY2012 | May 31, 2012 | $5.57M | +12.4% |
| FY2011 | May 31, 2011 | $4.96M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | $8.07M | +17.8% |
| Q4 FY2026CQ2 2026 | May 31, 2026 | $6.76M | +13.7% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | $4.88M | -33.9% |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $6.03M | -17.0% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | $6.85M | -12.9% |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $5.95M | -35.8% |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | $7.38M | -28.7% |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $7.27M | -38.5% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | $7.87M | -40.5% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $9.25M | -36.0% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | $10.34M | +26.0% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $11.83M | +19.4% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $13.22M | +19.6% |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $14.45M | +27.1% |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | $8.21M | -53.2% |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $9.91M | -33.1% |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | $11.05M | -4.0% |
| Q4 FY2022CQ2 2022 | May 31, 2022 | $11.37M | -3.8% |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | $17.56M | +31.6% |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | $14.81M | +2.3% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | $11.52M | -27.5% |
| Q4 FY2021CQ2 2021 | May 31, 2021 | $11.82M | -31.5% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $13.35M | +62.5% |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | $14.48M | +105.7% |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | $15.89M | +136.4% |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $17.26M | +229.1% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | $8.22M | +62.1% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | $7.04M | +29.7% |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | $6.72M | +37.9% |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $5.25M | +0.4% |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $5.07M | +6.5% |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | $5.43M | +12.4% |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | $4.88M | -0.8% |
| Q4 FY2018CQ2 2018 | May 31, 2018 | $5.22M | +4.1% |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | $4.76M | -13.1% |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | $4.83M | -13.5% |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | $4.91M | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | $5.02M | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | $5.48M | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | $5.59M | – |
See a number that looks wrong?